CPL-01

DRUG3 trials

Sponsors

Cali Pharmaceuticals LLC

Conditions

AbdominoplastyBunionInguinal HerniorrhaphyPostoperative Pain

Phase 2

Evaluate the Safety and Pharmacokinetic Profile of CPL-01 in the Management of Acute Postoperative Pain

CompletedNCT04182880

Cali Pharmaceuticals LLCAbdominoplasty

Start: 2020-01-06End: 2020-02-28Updated: 2026-04-13

A Phase 2, Randomized, Double-Blind, Dose Escalation Study in Postoperative Pain Open Inguinal Herniorrhaphy

CompletedNCT05080959

Cali Pharmaceuticals LLCInguinal Herniorrhaphy

Start: 2021-07-28End: 2022-06-10Updated: 2022-07-20

Phase 3

Phase 3 Bunionectomy Study

Not yet recruitingNCT07490496

Cali Pharmaceuticals LLCBunion, Postoperative Pain

Start: 2026-07-01End: 2026-11-28Target: 112Updated: 2026-03-27